Imagion Biosystems Limited (ASX: IBX) (Imagion or the Company) is pleased to announce a pro-rata non- renounceable rights issue (Offer) to shareholders, on the basis of 1 new share for every 2 Imagion shares held as at 7.00pm (Melbourne time) Friday 28 September 2018 (Record Date).
View the Pro-Rata Non-Renounceable Rights Issue announcement.
The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging
October 17, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the